Resultados de procura - Richard Knight

Limitar resultados
  1. 1
    PRION DISEASES

    PRION DISEASES por Richard Knight

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Immune Deficiency in Fetal Alcohol Syndrome

    Immune Deficiency in Fetal Alcohol Syndrome por Sharron Johnson, Richard Knight, Daniel J. Marmer, Russell W. Steele

    Publicado 1981
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism

    PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism por Matthew Bishop, Catherine Pennington, Craig A. Heath, Robert Will, Richard Knight

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    BK Virus–Associated Nephropathy in Sirolimus-Treated Renal Transplant Patients: Incidence, Course, and Clinical Outcomes

    BK Virus–Associated Nephropathy in Sirolimus-Treated Renal Transplant Patients: Incidence, Course, and Clinical Outcomes por Carlos Benavides, V. Pollard, Shamila Mauiyyedi, Hemangshu Podder, Richard Knight, Barry D. Kahan

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors.

    Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. por R Harries-Jones, Richard Knight, Robert Will, Simon Cousens, Peter G. Smith, W.B. Matthews

    Publicado 1988
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008

    Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008 por Mark Head, Helen Yull, Diane Ritchie, Jan Langeveld, Nicholas Fletcher, Richard Knight, James W. Ironside

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review

    The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review por Gurjit Chohan, Catherine Pennington, J. Mackenzie, Mary Andrews, Dawn Everington, R. G. Will, Richard Knight, A. J. E. Green

    Publicado 2010
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Variant CJD

    Variant CJD por Abigail B. Diack, Mark Head, Sandra McCutcheon, Aileen Boyle, Richard Knight, James W. Ironside, Jean Manson, Robert Will

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Molecular Barriers to Zoonotic Transmission of Prions

    Molecular Barriers to Zoonotic Transmission of Prions por Marcelo A. Barria, Aru Balachandran, Masanori Morita, Tetsuyuki Kitamoto, Rona Barron, Jean Manson, Richard Knight, James W. Ironside, Mark Head

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis

    Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis por Peter Newham, Daniel W. Ross, Peter Ceuppens, Shampa Das, James Yates, Catherine J. Betts, Jaimini Reens, Kevin J. Randall, Richard Knight, Jennifer S. McKay

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Spasmogenic Effects of the Proteasome Inhibitor Carfilzomib on Coronary Resistance, Vascular Tone and Reactivity

    Spasmogenic Effects of the Proteasome Inhibitor Carfilzomib on Coronary Resistance, Vascular Tone and Reactivity por Carol Chen‐Scarabelli, Giovanni Corsetti, Evasio Pasini, Francesco S. Dioguardi, Gagan Sahni, Jagat Narula, Mara Gavazzoni, Hemang Patel, Louis Saravolatz, Richard Knight, Riccardo Raddino, Tiziano M. Scarabelli

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Variably Protease-Sensitive Prionopathy, a Unique Prion Variant with Inefficient Transmission Properties

    Variably Protease-Sensitive Prionopathy, a Unique Prion Variant with Inefficient Transmission Properties por Abigail B. Diack, Diane Ritchie, Alexander Peden, Deborah Brown, Aileen Boyle, Laura Morabito, David H. MacLennan, Paul S. Burgoyne, Casper Jansen, Richard Knight, Pedro Piccardo, James W. Ironside, Jean Manson

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease

    Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease por Lynne I. McGuire, Alexander Peden, Christina D. Orrù, Jason M. Wilham, N. E. J. Appleford, Gary Mallinson, Mary Andrews, Mark Head, Byron Caughey, Robert Will, Richard Knight, Alison J. E. Green

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking-induced conversion

    Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking-induced conversion por Alexander Peden, Lynne I. McGuire, N. E. J. Appleford, Gary Mallinson, Jason M. Wilham, Christina D. Orrù, Byron Caughey, James W. Ironside, Richard Knight, Robert Will, Alison J. E. Green, Mark Head

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease

    Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease por Fabio Moda, Pierluigi Gambetti, Silvio Notari, Luis Concha‐Marambio, Marcella Catania, Kyung-Won Park, Emanuela Maderna, Silvia Suardi, Stéphane Haı̈k, J.-P. Brandel, James W. Ironside, Richard Knight, Fabrizio Tagliavini, Claudio Soto

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors por Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease

    Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease por Daisy Bougard, Jean‐Philippe Brandel, Maxime Bélondrade, Vincent Béringue, Christiane Segarra, Hervé Fleury, Jean Laplanche, Charly Mayran, Simon Nicot, Alison Green, Arlette Welaratne, D. Narbey, Chantal Fournier‐Wirth, Richard Knight, Robert Will, Pierre Tiberghien, Stéphane Haı̈k, Joliette Coste

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies

    Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies por Anna Ladogana, Pascual Sánchez‐Juan, E Mitrová, Alison Green, Natividad Cuadrado‐Corrales, Raquel Sánchez‐Valle, Silvia Koščová, Adriano Aguzzi, Theodoros Sklaviadis, J Kulczycki, Joanna Gawinecka, Albert Saiz, Miguel Calero, Cornelia M. van Duijn, Maurizio Pocchiari, Richard Knight, Inga Zerr

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis

    Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis por Pascual Sánchez‐Juan, Raquel Sánchez‐Valle, A. Green, Anna Ladogana, Natividad Cuadrado‐Corrales, E Mitrová, Katharina Stoeck, Theodoros Sklaviadis, J Kulczycki, Klaus Hess, Anna Krasnianski, Michele Equestre, Dana Žáková, Albert Saiz, Miguel Calero, Maurizio Pocchiari, Richard Knight, Cornelia M. van Duijn, Inga Zerr

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Patient-centred approaches for the management of unpleasant symptoms in kidney disease

    Patient-centred approaches for the management of unpleasant symptoms in kidney disease por Kamyar Kalantar‐Zadeh, Mark B. Lockwood, Connie M. Rhee, Ekamol Tantisattamo, Sharon Andreoli, Alessandro Balducci, Paul Laffin, Tess Harris, Richard Knight, Latha Kumaraswami, Vassilios Liakopoulos, Siu‐Fai Lui, Sajay Kumar, Maggie Ng, Gamal Saadi, Ifeoma Ulasi, Allison Tong, Philip Kam‐Tao Li

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: